PHARMACYCLICS INC's ticker is PCYC and the CUSIP is 716933106. A total of 344 filers reported holding PHARMACYCLICS INC in Q1 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $30,763,000 | +117.7% | 120,190 | +4.0% | 0.07% | +115.2% |
| Q4 2014 | $14,134,000 | +5.9% | 115,606 | +1.7% | 0.03% | 0.0% |
| Q3 2014 | $13,350,000 | +24.9% | 113,684 | -4.6% | 0.03% | +32.0% |
| Q2 2014 | $10,686,000 | -8.3% | 119,122 | +2.5% | 0.02% | -10.7% |
| Q1 2014 | $11,653,000 | -3.9% | 116,272 | +1.4% | 0.03% | -6.7% |
| Q4 2013 | $12,132,000 | – | 114,690 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 9,129,231 | $1,116,140,000 | 11.39% |
| DAFNA Capital Management LLC | 110,928 | $13,562,000 | 10.73% |
| HWG Holdings LP | 107,389 | $13,129,000 | 9.36% |
| Opaleye Management Inc. | 85,000 | $10,392,000 | 5.25% |
| Opus Point Partners Management, LLC | 25,723 | $3,145,000 | 3.11% |
| BB BIOTECH AG | 731,542 | $89,438,000 | 2.90% |
| Peregrine Asset Advisers, Inc. | 33,375 | $4,080,000 | 2.87% |
| HARVEY CAPITAL MANAGEMENT INC | 54,770 | $6,696,000 | 2.57% |
| Parametric Risk Advisors LLC | 300,000 | $36,678,000 | 2.45% |
| BENDER ROBERT & ASSOCIATES | 28,619 | $3,499,000 | 2.29% |